Tessera Defense increases MEA Testing Systems stake to 15% in cash-and-stock deal

Tessera retained an exclusive option to buy Motomova’s remaining MEA stake at a price tied to MEA’s audited fiscal 2027 results.

Tessera amended an investment agreement to lift its equity stake in M.E.A. Testing Systems to 15% from 10%.

Consideration was set at $50,000 in cash, 130,000 common shares, and 65,000 additional shares subject to NYSE American clearance.

The deal also includes a convertible loan facility of up to $475,000; Tessera may convert into additional MEA equity, subject to exchange approval.

Tessera also secured an exclusive, perpetual, worldwide license to MEA technology and know-how.